Could a simple blood test predict carpal tunnel severity?
NCT ID NCT06952647
First seen Jun 25, 2026 · Last updated Aug 12, 2026 · Updated 3 times
Summary
This study looked at whether certain blood markers of inflammation and vitamin B12 levels are linked to carpal tunnel syndrome. Researchers compared 70 people with and without the condition. The goal was to see if these markers could help explain why some cases are more severe.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could help identify simple blood tests to better understand or predict carpal tunnel syndrome severity.
- What could go wrong
- This is a small, completed observational study, not a treatment trial. The findings may not lead to any new tests or treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIOMARKERS / BLOOD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Physical Therapy and Rehabilitation, University of Health Sciences, Ankara Training and Research Hospital
Ankara, Altindag, 06230, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can sound waves or nerve glides ease carpal tunnel pain?
- Can a stem-cell wrap boost nerve repair after carpal tunnel surgery?
- Centenarians put to the test: can exercise reverse frailty at age 100?
- Could a common hand condition reveal hidden heart disease? new imaging trial investigates
- Laser light may help heal nerves in carpal tunnel syndrome
- AI mouse could give Pain-Free computing to millions with hand injuries